NFE2L2 and neoplasm: To determine whether the direct anticancer activity of RTA 405 is reduced in tumor cell lines with high NRF2 activity, we treated the panel of 20 tumor cell lines with RTA 405 ranging in concentration from 50 nM to 1000 nM and measured cell viability.